San Diego Heart Failure Symposiums

 

Preventing Cardiovascular Disease and Heart Failure
20:55

26th Annual San Diego Heart Failure Symposium

SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk

FEATURING Pam Taub
  • 897 views
  • December 16, 2020
  • 3
13:04

26th Annual San Diego Heart Failure Symposium

Recognizing and Treating Sleep Disordered Breathing: Impact on Patients with Heart Failure and Other Cardiovascular Diseases

FEATURING atul malhotra
  • 23 views
  • December 16, 2020
09:23

26th Annual San Diego Heart Failure Symposium

Q&A: Treating Hyperlipidemia, PAH and Other CV Diseases

FEATURING Barry Greenberg, Pam Taub, Daniel Blanchard, atul malhotra, Nick Kim
  • 33 views
  • December 16, 2020
15:21

26th Annual San Diego Heart Failure Symposium

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

FEATURING Pam Taub
  • 974 views
  • December 15, 2020
  • 9
21:22

26th Annual San Diego Heart Failure Symposium

Emerging Concepts in the Use of NOACs in AFib, CAD and DVT: How Do NOACs Compare to Warfarin? Is Rivaroxiban the Best Choice For Preventing VTE Events After Surgery?

FEATURING Daniel Blanchard
  • 220 views
  • December 15, 2020
  • 1
17:57

26th Annual San Diego Heart Failure Symposium

Treating Pulmonary Arterial Hypertension: Overview of FDA Approved Drugs and Importance of Combination Therapy

FEATURING Nick Kim
  • 600 views
  • December 15, 2020
  • 4